Private Capital Group’s Idexx Laboratories IDXX Stock Holding History

Private Capital Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$47K	Sell	135 -6	-4%	-$2.45K	0.04%	506
2022 Q1	$77K	Buy	141 +2	+1%	+$1.05K	0.02%	480
2021 Q4	$92K	Buy	139 +11	+9%	+$6.91K	0.02%	460
2021 Q3	$80K	Hold	128	–	–	0.02%	498
2021 Q2	$81K	Hold	128	–	–	0.02%	489
2021 Q1	$63K	Sell	128 -96	-43%	-$48.1K	0.02%	538
2020 Q4	$112K	Buy	224 +30	+15%	+$13.4K	0.02%	462
2020 Q3	$76K	Hold	194	–	–	0.02%	544
2020 Q2	$64K	Hold	194	–	–	0.01%	603
2020 Q1	$47K	Sell	194 -14	-7%	-$3.65K	0.01%	667
2019 Q4	$54K	Sell	208 -153	-42%	-$40.3K	0.01%	694
2019 Q3	$98K	Buy	361 +134	+59%	+$37.3K	0.02%	487
2019 Q2	$49K	Buy	227 +10	+5%	+$2.46K	0.01%	679
2019 Q1	$49K	Sell	217 -10	-4%	-$2.06K	0.01%	786
2018 Q4	$42K	Hold	227	–	–	0.01%	748
2018 Q3	$56K	Hold	227	–	–	0.01%	660
2018 Q2	$49K	Sell	227 -82	-27%	-$16.9K	0.01%	701
2018 Q1	$59K	Sell	309 -1	-0.3%	-$185	0.01%	597
2017 Q4	$17	Buy	+310	New	+$48.8K	﹤0.01%	1137

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Private Capital Group's IDXX Position: Q2 2022 in Review

Private Capital Group reduced its Idexx Laboratories (IDXX) stake by 4.3% in Q2 2022, selling an estimated $2.45K and leaving 135 shares worth $47K. The position accounts for 0.04% of the portfolio, ranked #506.

Private Capital Group first reported a position in IDXX in Q4 2017 and has held it in 19 quarters since. The position peaked at $112K in Q4 2020. 957 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

Private Capital Group held 135 shares of Idexx Laboratories worth $47K as of Q2 2022.
Private Capital Group sold 6 Idexx Laboratories shares in Q2 2022, an estimated $2.45K.
Idexx Laboratories made up 0.04% of Private Capital Group's portfolio in Q2 2022, its #506 holding.
Private Capital Group first reported a position in Idexx Laboratories in Q4 2017 and has held it in 19 quarters since.
Private Capital Group's Idexx Laboratories position peaked at $112K in Q4 2020.
957 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.